[1] |
Chen X, Li Y, Ding X, et al. Incidence, risk, and prognosis of cancer in patients on chronic hemodialysis [J]. Blood Purif, 2020, 49(3): 310-321.
|
[2] |
Pieroth R, Paver S, Day S, et al. Folate and its impact on cancer risk [J]. Curr Nutr Rep, 2018, 7(3): 70-84.
|
[3] |
Yuan S, Carter P, Vithayathil M, et al. Genetically predicted circulating B vitamins in relation to digestive system cancers [J]. Br J Cancer, 2021, 124(12): 1997-2003.
|
[4] |
Kawakita D, Lee YA, Gren LH, et al. The impact of folate intake on the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort [J]. Br J Cancer, 2018, 118(2): 299-306.
|
[5] |
He Z, Dang J, Song A, et al. The involvement of miR-150/β-catenin axis in colorectal cancer progression [J]. Biomed Pharmacother, 2020, 121: 109495.
|
[6] |
王珊,马清,杨华昱,等. 不同年龄段人群尿液外泌体中miR-150-5p对肾脏衰老的影响[J]. 中华老年医学杂志,2021, 40(11): 1386-1391.
|
[7] |
Zhang DQ, Li HW, Chen HP, et al. Combination of amino-terminal pro-BNP, estimated GFR, and high-sensitivity CRP for predicting cardiorenal syndrome type 1 in acute myocardial infarction patients [J]. J Am Heart Assoc, 2018, 7(19): e009162.
|
[8] |
王珊,杨华昱,姚兰,等. miR-21表达量与动脉粥样硬化程度的关系及长春西汀对其影响[J]. 中国医药导报,2017, 19(6):975-977.
|
[9] |
Shulpekova Y, Nechaev V, Kardasheva S, et al. The concept of folic acid in health and disease [J]. Molecules, 2021, 26(12): 3731.
|
[10] |
Oliai Araghi S, Kiefte-de Jong JC, van Dijk SC, et al. Folic acid and vitamin B12 supplementation and the risk of cancer: long-term follow-up of the B vitamins for the prevention of osteoporotic fractures (B-PROOF) trial [J]. Cancer Epidemiol Biomarkers Prev, 2019, 28(2): 275-282.
|
[11] |
Kanarek N, Petrova B, Sabatini DM. Dietary modifications for enhanced cancer therapy [J]. Nature, 2020, 579(7800): 507-517.
|
[12] |
Senti FR, Pilch SM. Analysis of folate data from the second National Health and Nutrition Examination Survey (NHANES II) [J]. J Nutr, 1985, 115(11): 1398-1402.
|
[13] |
Ivanovski N, Stojceva-Taneva O, Grozdanovski R, et al. Short-term effect of folic acid supplementation in renal transplant recipients and chronic kidney disease patients with comparable renal function impairment [J]. Nephrologie, 2004, 25(7): 301-303.
|
[14] |
Mayne ST, Risch HA, Dubrow R, et al. Nutrient intake and risk of subtypes of esophageal and gastric cancer [J]. Cancer Epidemiol Biomarkers Prev, 2001, 10(10): 1055-1062.
|
[15] |
Giovannucci E, Stampfer MJ, Colditz GA, et al. Multivitamin use, folate, and colon cancer in women in the Nurses′ Health Study [J]. Ann Intern Med, 1998, 129(7): 517-524.
|
[16] |
Vollset SE, Clarke R, Lewington S, et al. Effects of folic acid supplementation on overall and site-specific cancer incidence during the randomised trials: meta-analyses of data on 50,000 individuals [J]. Lancet, 2013, 381(9871): 1029-1036.
|
[17] |
Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer [J]. Dis Model Mech, 2021, 14(4): dmm047662.
|
[18] |
Chen L, Heikkinen L, Wang C, et al. Trends in the development of miRNA bioinformatics tools [J]. Brief Bioinform, 2019, 20(5): 1836-1852.
|
[19] |
Zhang J, Luo N, Luo Y, et al. microRNA-150 inhibits human CD133-positive liver cancer stem cells through negative regulation of the transcription factor c-Myb [J]. Int J Oncol, 2012, 40(3): 747-756.
|
[20] |
Liu H, Liu R, Hao M, et al. Kinesin family member 3C (KIF3C) is a novel non-small cell lung cancer (NSCLC) oncogene whose expression is modulated by microRNA-150-5p (miR-150-5p) and microRNA-186-3p (miR-186-3p) [J]. Bioengineered, 2021, 12(1): 3077-3088.
|
[21] |
Aherne ST, Madden SF, Hughes DJ, et al. Circulating miRNAs miR-34a and miR-150 associated with colorectal cancer progression [J]. BMC Cancer, 2015, 15: 329.
|
[22] |
Zhang ZC, Wang GP, Yin LM, et al. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells [J]. Eur Rev Med Pharmacol Sci, 2018, 22(20): 6793-6800.
|